Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Open accessThe DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index.
Abstract
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure (mPAP) ≥25 mmHg at rest, measured by right heart catheterisation. Recent data from normal subjects has shown that normal mPAP was 14.0±3.3 mmHg. Two standard deviations above this mean value would suggest mPAP >20 mmHg as above the upper limit of normal (above the 97.5th percentile). This definition is no longer arbitrary, but based on a scientific approach. However, this abnormal elevation of mPAP is not sufficient to define pulmonary vascular disease as it can be due to an increase in cardiac output or pulmonary arterial wedge pressure. Thus, this 6th WSPH Task Force proposes to include pulmonary vascular resistance ≥3 Wood Units in the definition of all forms of pre-capillary PH associated with mPAP >20 mmHg. Prospective trials are required to determine whether this PH population might benefit from specific management. Regarding clinical classification, the main Task Force changes were the inclusion in group 1 of a subgroup “pulmonary arterial hypertension (PAH) long-term responders to calcium channel blockers”, due to the specific prognostic and management of these patients, and a subgroup “PAH with overt features of venous/capillaries (pulmonary veno-occlusive disease/pulmonary capillary haemangiomatosis) involvement”, due to evidence suggesting a continuum between arterial, capillary and vein involvement in PAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1 The slope of the mean pulmonary arterial pressure (mPAP)–cardiac output (CO) relationship is different in normal control versus pulmonary arterial hypertension (PAH) subjects. Reproduced and modified from [26] with permission.](https://figures.cochat.ai/paper-figures/36e057af8c4544adb1c352faf9a06761/haemodynamic-definitions-and-updated-clinical-classification-of-pulmonary-figure-1.jpg)
![FIGURE 2 Knowledge of the mean pulmonary arterial pressure (mPAP)–cardiac output (CO) relationship does not allow distinction between left heart disease (LHD) and pulmonary vascular disease (PVD) patients; knowledge of exercise pulmonary arterial wedge pressure is also required. TPR: total pulmonary resistance; WU: Wood Units. Reproduced from [29] with permission.](https://figures.cochat.ai/paper-figures/8474dfd09d604465902cbdde1d1fd85a/haemodynamic-definitions-and-updated-clinical-classification-of-pulmonary-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the World Symposium of Pulmonary Hypertension classification of PAH, group 1 is the most common indication.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Group 2, with decreased left ventricular function, is not an indication for transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Pulmonary hypertension can also occur in the context of congenital heart disease.(301)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [301]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“group 3 with PAH and accompanying pathological changes in the lung parenchyma can be considered for transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The current consensus is based on 2 tools for referral and listing: the REVEAL Registry 2.2 (Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management 2.0) and 2015 European Society of Cardiology/European Respiratory Society.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationDe Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationGaliè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationUpdated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Self-citationClinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Self-citationDefinitions and Diagnosis of Pulmonary Hypertension
Hoeper, M. M., Bogaard, H. J., Condliffe, R., Frantz, R., Khanna, D., Kurzyna, M., Langleben, D., Manes, A., Satoh, T., Torres, F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.032 · Cited by 1,766
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,550
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
Self-citation
Research works printed but not linked: 2
- Reeves J , Dempsey J , Grover R . Pulmonary circulation during exercise. In: Weir EK , Reeves JT , eds. Pulmonary Vascular Physiology and Physiopathology. New York, Marcel Dekker, 1989; pp. 107–133. · doi:10.1201/9781003573739-5
- Tamura Y , Furukawa A , Li T , et al. Severe pulmonary arterial hypertension in patients treated by Chinese herb nature indigo: Qing-Dai. Poster presentation at the 6th World Symposium on Pulmonary Hypertension, Nice, 2018; A108.
Cited by
Items 101–200 of 1,004
Updated Perspectives on Pulmonary Hypertension in COPD
Blanco, I., Tura-Ceide, O., Peinado, V. I., & Barberà, J. A. (2020) · International Journal of COPD · doi:10.2147/copd.s211841 · Cited by 115
Imaging of Pulmonary Hypertension in Adults: A Position Paper from the Fleischner Society
Rémy‐Jardin, M., Ryerson, C. J., Schiebler, M. L., Leung, A. N. C., Wild, J. M., Hoeper, M. M., Alderson, P. O., Goodman, L. R., Mayo, J. R., Haramati, L. B., et al. (2021) · Radiology · doi:10.1148/radiol.2020203108 · Cited by 115
Hemnes, A. R., Leopold, J. A., Radeva, M., Beck, G. J., Abidov, A. A., Aldred, M. A., Barnard, J., Rosenzweig, E. B., Borlaug, B. A., Chung, W. K., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.05.038 · Cited by 115
Flavonoids: Potential therapeutic agents for cardiovascular disease
Liu, Y., Luo, J., Peng, L., Zhang, Q., Rong, X., Luo, Y., & Li, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32563 · Cited by 115
Knock, G. A. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.029 · Cited by 109
Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening
Liu, S., Veetil, N. N., Li, Q., Kucherenko, M. M., Knosalla, C., & Kuebler, W. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.959209 · Cited by 114
Pulmonary hypertension in chronic obstructive pulmonary disease
Gredic, M., Blanco, I., Kovács, G., Helyes, Z., Ferdinandy, P., Olschewski, H., Barberà, J. A., & Weißmann, N. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14979 · Cited by 113
Right Heart Failure in Pulmonary Hypertension
Cassady, S. J., & Ramani, G. V. (2020) · Cardiology Clinics · doi:10.1016/j.ccl.2020.02.001 · Cited by 113
Xanthouli, P., Jordan, S., Milde, N., Marra, A. M., Blank, N., Egenlauf, B., Gorenflo, M., Harutyunova, S., Lorenz, H., Nagel, C., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216476 · Cited by 112
The application of big data to cardiovascular disease: paths to precision medicine
Leopold, J. A., Maron, B. A., & Loscalzo, J. (2020) · Journal of Clinical Investigation · doi:10.1172/jci129203 · Cited by 111
Greif, R., Bray, J., Djärv, T., Drennan, I. R., Liley, H. G., Ng, K.-C., Cheng, A., Douma, M. J., Scholefield, B. R., Smyth, M., et al. (2024) · Resuscitation · doi:10.1016/j.resuscitation.2024.110414 · Cited by 111
Karnati, S., Seimetz, M., Kleefeldt, F., Sonawane, A., Madhusudhan, T., Bachhuka, A., Kosanovic, D., Weißmann, N., Krüger, K., & Ergün, S. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.649512 · Cited by 109
Emmons‐Bell, S., Johnson, C. O., Boon-Dooley, A. S., Corris, P. A., Leary, P. J., Rich, S., Yacoub, M. H., & Roth, G. A. (2021) · Pulmonary Circulation · doi:10.1002/pul2.12020 · Cited by 109
Obesity Is Associated With Pulmonary Hypertension and Modifies Outcomes
Frank, R. C., Min, J., Abdelghany, M., Paniagua, S. M., Bhattacharya, R., Bhambhani, V., Pomerantsev, E. V., & Ho, J. E. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014195 · Cited by 108
Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension
Nickel, N. P., Yuan, K., Dorfmüller, P., Provencher, S., Lai, Y., Bonnet, S., Austin, E. D., Koch, C. D., Morris, A., Perros, F., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0656ci · Cited by 107
Self-citationCharacterization of Kcnk3 -Mutated Rat, a Novel Model of Pulmonary Hypertension
Lambert, M., Capuano, V., Boët, A., Tesson, L., Bertero, T., Nakhleh, M. K., Remy, S., Anegón, I., Péchoux, C., Hautefort, A., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.314793 · Cited by 106
Self-citationBootsma, I. T., Boerma, E. C., Scheeren, T., & de Lange, F. (2021) · Journal of Clinical Monitoring and Computing · doi:10.1007/s10877-021-00673-5 · Cited by 106
Pulmonary Hypertension and Pregnancy
Martin, S., & Edwards, A. (2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003549 · Cited by 105
ACOG Practice Bulletin No. 212: Pregnancy and Heart Disease
Moussa, H. N., & Rajapreyar, I. N. (2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003497 · Cited by 105
Screening for pulmonary arterial hypertension in systemic sclerosis
Weatherald, J. C., Montani, D., Jevnikar, M., Jaïs, X., Savale, L., & Humbert, M. J. C. (2019) · European Respiratory Review · doi:10.1183/16000617.0023-2019 · Cited by 104
Self-citationRuffenach, G., Hong, J. S., Vaillancourt, M., Medzikovic, L., & Eghbali, M. (2020) · Respiratory Research · doi:10.1186/s12931-020-01570-2 · Cited by 104
Wu, Y., Pan, B., Zhang, Z., Li, X., Leng, Y., Ji, Y., Sun, K., & Chen, A. F. (2022) · Hypertension · doi:10.1161/hypertensionaha.121.17868 · Cited by 104
Phenotypic Diversity of Vascular Smooth Muscle Cells in Pulmonary Arterial Hypertension
Lechartier, B., Berrebeh, N., Huertas, A., Humbert, M. J. C., Guignabert, C., & Tu, L. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.08.040 · Cited by 102
Echocardiographic probability of pulmonary hypertension: a validation study
D’Alto, M., Maio, M. D., Romeo, E., Argiento, P., Blasi, E., Vilio, A. D., Rea, G., D’Andrea, A., Golino, P., & Naeije, R. (2022) · European Respiratory Journal · doi:10.1183/13993003.02548-2021 · Cited by 101
Hsu, S., Simpson, C. E., Houston, B. A., Wand, A. L., Sato, T., Kolb, T. M., Mathai, S. C., Kass, D. A., Hassoun, P. M., Damico, R. L., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.016031 · Cited by 100
Chronic Thromboembolic Pulmonary Hypertension
Papamatheakis, D. G., Poch, D. S., Fernandes, T. M., Kerr, K. M., Kim, N. H., & Fedullo, P. F. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.074 · Cited by 100
Tobal, R., Potjewijd, J., van Empel, V. P. M., Ysermans, R., Schurgers, L. J., Reutelingsperger, C. P. M., Damoiseaux, J. G. M. C., & van Paassen, P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.806899 · Cited by 99
Pulmonary Arterial Hypertension: a Pharmacotherapeutic Update
Coons, J. C., Pogue, K. T., Kolodziej, A., Hirsch, G. A., & George, M. P. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1235-4 · Cited by 98
Zhu, N., Świetlik, E. M., Welch, C. L., Pauciulo, M. W., Hagen, J., Zhou, X., Guo, Y., Karten, J., Pandya, D., Tilly, T., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00891-1 · Cited by 98
Self-citationGroup 3 Pulmonary Hypertension: From Bench to Bedside
Singh, N., Dorfmüller, P., Shlobin, O. A., & Ventetuolo, C. E. (2022) · Circulation Research · doi:10.1161/circresaha.121.319970 · Cited by 98
Understanding exosomes: Part 2—Emerging leaders in regenerative medicine
Miron, R. J., Estrin, N. E., Sculean, A., & Zhang, Y. (2024) · Periodontology 2000 · doi:10.1111/prd.12561 · Cited by 98
Sex Differences in Right Ventricular–Pulmonary Arterial Coupling in Pulmonary Arterial Hypertension
Tello, K., Richter, M. J., Yogeswaran, A., Ghofrani, H. A., Naeije, R., Vanderpool, R. R., Gall, H. J., Tedford, R. J., Seeger, W., & Lahm, T. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0807le · Cited by 97
Steffes, L. C., Froistad, A. A., Andruska, A., Boehm, M., McGlynn, M. N., Zhang, F., Zhang, W., Hou, D., Tian, X., Miquerol, L., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.045750 · Cited by 97
Christou, H. A., & Khalil, R. A. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00021.2022 · Cited by 97
Lewis, R. A., Thompson, A. A. R., Billings, C., Charalampopoulos, A. F., Elliot, C. A., Hamilton, N., Hill, C., Hurdman, J. A., Rajaram, S., Sabroe, I., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00041-2020 · Cited by 96
Ni, J.-R., Yan, P., Liu, S., Hu, Y. L., Yang, K., Song, B., & Lei, J.-Q. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-033084 · Cited by 95
Animal models of pulmonary hypertension: Getting to the heart of the problem
Dignam, J. P., Scott, T., Kemp‐Harper, B. K., & Hobbs, A. J. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15444 · Cited by 95
French recommendations for the management of systemic sclerosis
HACHULLA, E., Agard, C., Allanore, Y., Avouac, J., Bader‐Meunier, B., Bélot, A., BEREZNE, A., Bouthors, A., Condette-Wojtasik, G., Constans, J., et al. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01844-y · Cited by 94
Pulmonary Hypertension Definition, Classification, and Epidemiology in Asia
Anderson, J., & Lau, E. (2022) · JACC Asia · doi:10.1016/j.jacasi.2022.04.008 · Cited by 94
Jee, A. S., Sheehy, R. D., Hopkins, P. M.-A., Corte, T. J., Grainge, C., Troy, L. K., Symons, K., Spencer, L., Reynolds, P. N., Chapman, S. A., et al. (2020) · Respirology · doi:10.1111/resp.13977 · Cited by 93
BMP9 and BMP10 : Two close vascular quiescence partners that stand out
Desroches‐Castan, A., Tillet, E., Bouvard, C., & Bailly, S. (2021) · Developmental Dynamics · doi:10.1002/dvdy.395 · Cited by 93
Pulmonary hypertension phenotypes in patients with systemic sclerosis
Haque, A., Kiely, D. G., Kovács, G., Thompson, A. A. R., & Condliffe, R. A. (2021) · European Respiratory Review · doi:10.1183/16000617.0053-2021 · Cited by 93
Neutralization of CXCL12 attenuates established pulmonary hypertension in rats
Bordenave, J., Thuillet, R., Tu, L., Phan, C., Cumont, A., MARSOL, C., Huertas, A., Savale, L., Hibert, M., Galzi, J., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz153 · Cited by 93
Cardiovascular complications of sickle cell disease
Sachdev, V., Rosing, D. R., & Thein, S. L. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.02.002 · Cited by 92
Dachs, T.-M., Duca, F., Rettl, R., Binder, C., Dalos, D., Ligios, L. C., Kammerlander, A. A., Grünig, E., Pretsch, I., Steringer‐Mascherbauer, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac389 · Cited by 92
Pulmonary Vascular Remodeling in Pulmonary Hypertension
Jia, Z., Wang, S., Yan, H., Cao, Y., Zhang, X., Wang, L., Zhang, Z., Lin, S., Wang, X., & Mao, J. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13020366 · Cited by 92
Lung transplantation for interstitial lung disease
Kapnadak, S. G., & Raghu, G. (2021) · European Respiratory Review · doi:10.1183/16000617.0017-2021 · Cited by 91
The revised definition of pulmonary hypertension: exploring the impact on patient management
Simonneau, G., & Hoeper, M. M. (2019) · European Heart Journal Supplements · doi:10.1093/eurheartj/suz211 · Cited by 91
Self-citationScreening strategies for pulmonary arterial hypertension
Kiely, D. G., Lawrie, A., & Humbert, M. J. C. (2019) · European Heart Journal Supplements · doi:10.1093/eurheartj/suz204 · Cited by 91
Bordenave, J., Tu, L., Berrebeh, N., Thuillet, R., Cumont, A., Vely, B. L., Fadel, É., Nadaud, S., Savale, L., Humbert, M. J. C., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313715 · Cited by 91
Bauer, Y., de Bernard, S., Hickey, P. M., Ballard, K., Cruz, J. P., Cornelisse, P., Chadha‐Boreham, H., Distler, O., Rosenberg, D., Doelberg, M., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.02591-2020 · Cited by 91
Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease
Rahaghi, F., Kolaitis, N. A., Adegunsoye, A., de Andrade, J. A., Flaherty, K. R., LANCASTER, L. H., Lee, J. S., Levine, D. J., Preston, I. R., Safdar, Z., et al. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.02.012 · Cited by 90
Oxidative Stress and Antioxidative Therapy in Pulmonary Arterial Hypertension
Xu, D., Hu, Y., Gou, X., Li, F.-Y., Yang, X.-Y.-C., Li, Y., & Chen, F. (2022) · Molecules · doi:10.3390/molecules27123724 · Cited by 90
Effect of mode of intraoperative support on primary graft dysfunction after lung transplant
Loor, G., Huddleston, S. J., Hartwig, M. G., Bottiger, B., Daoud, D., Wei, Q., Zhang, Q., Ius, F., Warnecke, G., Villavicencio, M. A., et al. (2022) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.10.076 · Cited by 89
Clinical Update on Pulmonary Hypertension
Yaghi, S., Novikov, A., & Trandafirescu, T. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001291 · Cited by 88
Targeting Jak–Stat Signaling in Experimental Pulmonary Hypertension
Yerabolu, D., Weiß, A., Kojonazarov, B. K., Boehm, M., Schlueter, B. C., Ruppert, C., Günther, A., Jonigk, D. D., Grimminger, F., Ghofrani, H. A., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0431oc · Cited by 88
Pulmonary arterial hypertension specific therapy: The old and the new
Zolty, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107576 · Cited by 87
Performance and Interpretation of Invasive Hemodynamic Exercise Testing
Jain, C. C., & Borlaug, B. A. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.05.552 · Cited by 87
Frataxin deficiency promotes endothelial senescence in pulmonary hypertension
Culley, M. K., Zhao, J., Tai, Y., Tang, Y., Perk, D., Negi, V., Yu, Q., Woodcock, C.-S. C., Handen, A. L., Speyer, G., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci136459 · Cited by 87
Aldred, M. A., Morrell, N. W., & Guignabert, C. (2022) · Circulation Research · doi:10.1161/circresaha.122.320084 · Cited by 87
Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial Hypertension
Masson, B., Ribeuz, H. L., Sabourin, J., Laubry, L., Woodhouse, E., Foster, R., Ruchon, Y., Dutheil, M., Boët, A., Ghigna, M., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.321041 · Cited by 87
Self-citationPan, Z., Marra, A. M., Benjamin, N., Eichstaedt, C. A., Blank, N., Bossone, E., Cittadini, A., Coghlan, G., Denton, C. P., Distler, O., et al. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1981-0 · Cited by 86
Self-citationGuidelines for the Treatment of Pulmonary Arterial Hypertension
Vazquez, Z. G. S., & Klinger, J. R. (2020) · Lung · doi:10.1007/s00408-020-00375-w · Cited by 86
Young, A., Vummidi, D., Visovatti, S., Homer, K., Wilhalme, H., White, E. S., Flaherty, K., McLaughlin, V., & Khanna, D. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40862 · Cited by 85
Avdeev, S. N., Барбараш, О. Л., Солтановна, В. З., Volkov, A. V., Veselova, T. N., Galyavich, A. S., Goncharova, N. S., Gorbachevsky, S. V., Владимирович, Г. В., Danilov, N. M., et al. (2024) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2024-6161 · Cited by 85
Tello, K., Seeger, W., Naeije, R., Vanderpool, R. R., Ghofrani, H. A., Richter, M. J., Tedford, R. J., & Bogaard, H. J. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14866 · Cited by 84
2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease
Pelliccia, A., Sharma, S., Gati, S., Bäck, M., Börjesson, M., Caselli, S., Collet, J., Corrado, D., Drezner, J. A., Halle, M., et al. (2021) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2021.05.003 · Cited by 84
Exercise-based rehabilitation programmes for pulmonary hypertension
Morris, N. R., Kermeen, F. D., Jones, A. W., Lee, J. Y. T., & Holland, A. E. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011285.pub3 · Cited by 84
Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics.
Brassington, K., Selemidis, S., Bozinovski, S., & Vlahos, R. (2022) · PubMed Central · doi:10.1042/cs20210835 · Cited by 43
Introduction to Radio Propagation for Fixed and Mobile Communications
Doble, J. E. (1996) · International Linear Collider · Cited by 83
Ryanto, G. R. T., Ikeda, K., Miyagawa, K., Tu, L., Guignabert, C., Humbert, M. J. C., Fujiyama, T., Yanagisawa, M., Hirata, K., & Emoto, N. (2021) · Nature Communications · doi:10.1038/s41467-021-21961-3 · Cited by 82
McGlothlin, D. P., Granton, J. T., Klepetko, W., Beghetti, M., Rosenzweig, E. B., Corris, P. A., Horn, E. M., Kanwar, M. K., McRae, K. M., Román, A., et al. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.06.013 · Cited by 82
Self-citationBalistrieri, A., Makino, A., & Yuan, J. X. ‐. (2022) · Physiological Reviews · doi:10.1152/physrev.00030.2021 · Cited by 81
Tello, K., Dalmer, A., Vanderpool, R. R., Ghofrani, H. A., Naeije, R., Roller, F. C., Seeger, W., Wiegand, M. A., Gall, H. J., & Richter, M. J. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00485.2019 · Cited by 81
The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension
Roger, I., Milara, J., Montero, P., & Cortijo, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094980 · Cited by 80
Guignabert, C., Savale, L., Boucly, A., Thuillet, R., Tu, L., Ottaviani, M., Rhodes, C. J., de Groote, P., Prévôt, G., Bergot, E., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.061501 · Cited by 80
Self-citationFamilial pulmonary arterial hypertension byKDRheterozygous loss of function
Eyries, M., Montani, D., Girerd, B., Favrolt, N., Riou, M., Faivre, L. O., Manaud, G., Perros, F., Gräf, S., Morrell, N. W., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.02165-2019 · Cited by 80
Self-citationEURASIAN CLINICAL GUIDELINES ON DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION
Chazova, I. E., Martynyuk, T. V., Солтановна, В. З., Азизов, В. А., Барбараш, О. Л., Veselova, T. N., Galyavich, A. S., Gorbachevsky, S. V., Zelveian, P., Лазарева, И. В., et al. (2020) · Eurasian heart journal · doi:10.38109/2225-1685-2020-1-78-122 · Cited by 80
Boon, G. J. A. M., Ende-Verhaar, Y. M., Bavalia, R., el Bouazzaoui, L. H., Delcroix, M., Dzikowska‐Diduch, O., Huisman, M. V., Kurnicka, K., Mairuhu, A. T. A., Middeldorp, S., et al. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-216324 · Cited by 80
Management of Pulmonary Arterial Hypertension
Mayeux, J. D., Pan, I. Z., Dechand, J., Jacobs, J. A., Jones, T. L., McKellar, S. H., Beck, E. M., Hatton, N. D., & Ryan, J. J. (2020) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-020-00663-3 · Cited by 79
Phenotype and outcome of pulmonary arterial hypertension patients carrying aTBX4mutation
Thoré, P., Girerd, B., Jaïs, X., Savale, L., Ghigna, M., Eyries, M., Lévy, M., Ovaert, C., Servettaz, A., Guillaumot, A., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.02340-2019 · Cited by 78
Self-citationPortopulmonary Hypertension: From Bench to Bedside
Thomas, C., Glinskii, V. V., Pérez, V. D. J., & Sahay, S. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.569413 · Cited by 78
Experimental animal models of pulmonary hypertension: Development and challenges
Wu, X., Ma, J., Ding, D., Ma, Y., Wei, Y., & Jing, Z. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12220 · Cited by 78
Chronic thromboembolic pulmonary hypertension: the magic of pathophysiology
Simonneau, G., Dorfmüller, P., Guignabert, C., Mercier, O. M., & Humbert, M. J. C. (2021) · Annals of Cardiothoracic Surgery · doi:10.21037/acs-2021-pte-10 · Cited by 77
Self-citationKim, D., & George, M. P. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.12.002 · Cited by 77
Errington, N., Iremonger, J., Pickworth, J. A., Kariotis, S., Rhodes, C. J., Rothman, A. M. K., Condliffe, R. A., Elliot, C. A., Kiely, D. G., Howard, L., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103444 · Cited by 76
Bouvard, C., Tu, L., Rossi, M., Desroches-Castan, A., Berrebeh, N., Helfer, E., Roelants, C., Liu, H., Ouarné, M., Chaumontel, N., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvab187 · Cited by 75
Pulmonary hypertension in connective tissue diseases, new evidence and challenges
Vonk, M. C., Vandecasteele, E. H., & van Dijk, A. P. J. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13453 · Cited by 75
Rubio‐Rivas, M., Homs, N. A., Cuartero, D., & Corbella, X. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102713 · Cited by 75
Rahaghi, F. N., Nardelli, P., Harder, E. M., Singh, I., Vegas‐Sánchez‐Ferrero, G., Ross, J. C., Estépar, R. S. J., Ash, S. Y., Hunsaker, A. R., Maron, B. A., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.06.069 · Cited by 75
Endothelial Senescence: A New Age in Pulmonary Hypertension
Culley, M. K., & Chan, S. Y. (2022) · Circulation Research · doi:10.1161/circresaha.121.319815 · Cited by 75
Eichstaedt, C. A., Belge, C., Chung, W. K., Gräf, S., Grünig, E., Montani, D., Quarck, R. A., Tenorio, J. A., Soubrier, F., Trembath, R. C., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01471-2022 · Cited by 75
Self-citationKhanna, D., Zhao, C., Saggar, R., Mathai, S. C., Chung, L. S., Coghlan, G., Shah, M., Hartney, J. M., & McLaughlin, V. V. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41669 · Cited by 74
Prisco, S. Z., Rose, L., Potus, F., Tian, L., Wu, D., Hartweck, L. M., Al‐Qazazi, R., Neuber‐Hess, M. S., Eklund, M., Hsu, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197278 · Cited by 73
Wu, D., Dasgupta, A., Read, A. D., Bentley, R. E. T., Motamed, M., Chen, K., Al‐Qazazi, R., Mewburn, J. D., Dunham‐Snary, K. J., Alizadeh, E., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.452 · Cited by 73
Tana, C., Drent, M., Nunès, H., Kouranos, V., Cinetto, F., Jessurun, N. T., & Spagnolo, P. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2063375 · Cited by 73
Wang, X., Wang, Y., Yuan, T., Wang, H., Zeng, Z., Tian, L., Cui, L., Guo, J., & Chen, Y. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156062 · Cited by 73
Macrophage-derived PDGF-B induces muscularization in murine and human pulmonary hypertension
Ntokou, A., Dave, J. M., Kauffman, A. C., Sauler, M., Ryu, C., Hwa, J., Herzog, E. L., Singh, I., Saltzman, W. M., & Greif, D. M. (2021) · JCI Insight · doi:10.1172/jci.insight.139067 · Cited by 73
Gall, H. J., Yogeswaran, A., Fuge, J., Sommer, N., Grimminger, F., Seeger, W., Olsson, K. M., Hoeper, M. M., Richter, M. J., Tello, K., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100822 · Cited by 72
Hipertensión arterial pulmonar
Luna‐López, R., Martín, A. R., & Subías, P. E. (2022) · Medicina Clínica · doi:10.1016/j.medcli.2022.01.003 · Cited by 72
Metadata
- Authors
- Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R.
- Affiliations
- Université Paris-Sud (FR)
- The University of Sydney (AU)
- The Royal Free Hospital (GB)
- Mayo Clinic (US)
- Milpark Hospital (ZA)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801913
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351336
- OpenAlex
- W2904180601
- Cited by
- 3,813
- References
- 87
- Citations by year
- 2026: 208 · 2025: 356 · 2024: 480 · 2023: 541 · 2022: 716 · 2021: 711 · 2020: 558 · 2019: 225
- FWCI
- 282.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-LABX-0033)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Keywords
- pulmonary hypertension, clinical classification, precapillary pulmonary hypertension, pulmonary arterial hypertension, pulmonary vascular resistance, mean pulmonary artery pressure, pulmonary vascular disease, pulmonary veno-occlusive disease, calcium channel blockers, right heart catheterization, reference values
- MeSH terms
- Consensus Statements as Topic, Heart Diseases, Hemodynamics, Humans, Hypertension, Pulmonary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.